Aimedis IDO

Aimedis IDO

Created using Figma
Aimedis - an eHealth platform based on blockchain technology, which has been developed since 2017 and released in the current version 2020 for web, iOS and Android. Aimedis combineseHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, emergency records and much more along with medical social media platform, eLearning, eTeaching and education, a unique medical and scientific-pharmaceutical NFT marketplace, while displaying all relevant operations in a private blockchain, visible and transparent for the patient. Aimedis builds the world’s first medical metaverse and opens the world’s first virtual hospital chain in the metaverse while offering space to other hospitals, companies, universities and people.
  • 市场
    价钱
    第24H卷
    24H(价格)
    24H(体积)
  • BitMart
    AIMX/USDT 一年前
    $ 0.0201
    $ 223.606 K
    -
    -
  • ProBit Global
    AIMX/USDT 一年前
    $ 0.0071
    $ 18.141 K
    -
    -
To be announced
令牌详细信息
断续器
AIMX
公司详情
注册国家
Netherlands
额外细节
MVP /原型
分类
平台, 健康

关于 Aimedis IDO

Aimedis combines all relevant eHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, medical social media communication, eLearning, the world's first medical and scientific-pharmaceutical NFT marketplace, while displaying all relevant operations in a private blockchain, visible and transparent for the patient. The Aimedis token, which is tailored to the platform, is much more than just utility and payment tokens, it also offers staking, governance, DeFi (the first medical DeFi token) and the next hot trend in the field of cryptocurrencies, social token functionalities . Aimedis has already generated more than 1.4M USD in 2020 and is active on several continents.

Aimedis combines your health data, onliner prescriptions, video consultation with doctors and psychologists, information, medical hardware, your smart devices, and more on a single platform on your PC, your smartphone or your tablet, anytime, worldwide and in multiple languages.

Blockchain smart contracts smart graphs artificial intelligence highest security standards payments cryptocurrencies ICD ATC HL7 FHIR HIPPA IHE DICOM.

Soon Aimedis will offer much more including AIMSocial - the interactive patient platform that is secured and supported by a blockchain and help patients to support each other on a new level.

 

特征

• Digital therapy & healthcare services
• B2B business – medical & scientific data NFT marketplace
• Hospital & rehab information system
• Advertising platform for healthcare providers & pharma
• Data platform for pharmaceutical and healthcare research
• IoT & tracker integration
• Insurance program hubs
• Online pharmacy and shop
• A steadily growing medical ecosystem
• Incentivized growing educational and social medical network
• eLearning & eTeaching

%name%Roadmap

  • Q1 2022

  • Public launch of Aimedis DataXChange NFT marketplace including new trials

    First version of Aimedis Avalon including Aimedis Virtual Campus & Aimedis Museum of Virtual Medical Art V1 release in Unreal Engine 5 and Aimedis NFTs
  • Q2 2022

  • Aimedis – Alpha Hospital opening

    Public release of Aimedis Virtual Hospital and Rehab
  • Q3 2022

  • Aimedis Pharmacy & IoT incl. implementation with Aimedis Health
  • Q4 2022

  • Aimedis Blockchain: AIMChain V4 release including further decentralization

Aimedis IDO 球队

验证 0%

注意。未经证实的成员实际上可能不是团队成员

Dr. Henry Adapon
MD - President
未验证
Benny Adapon
Manager of Strategic Planning
未验证
Daniella B. Sevilla
Director of Digital Marketing
未验证
Matthew Rutter
COO
未验证
Michael J. Kaldasch
CEO, MD & founder
未验证
Ben O. El Idrissi
COO, MD & founder
未验证
Roxana Nasoi
M.Sc. CCO & Partnerships
未验证

2 ICO

$3 288 740

Miguel Sanchez De Pe...
CFO
未验证
Jack Yehoshua Westov...
CBO
未验证
Benjamin C. Sevilla
Chairman
未验证

Aimedis IDO 最新消息

  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。